Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial metabolic states and membrane potential modulate mtNOS activity.

Laura B Valdez1, Tamara Zaobornyj, Alberto Boveris

  • 1Laboratory of Free Radical Biology, School of Pharmacy and Biochemistry, University of Buenos Aires, Junín 956, C1113AAD, Buenos Aires, Argentina. lbvaldez@ffyb.uba.ar

Biochimica Et Biophysica Acta
|April 21, 2006
PubMed
Summary

Mitochondrial nitric oxide (NO) release is regulated by metabolic state and membrane potential. NO release is lower in state 3 than state 4, driven by membrane potential, not pH.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>N</i>-Acetylcysteine Treatment Restores the Protective Effect of Heart Ischemic Postconditioning in a Murine Model in the Early Stages of Atherosclerosis.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model.

Antioxidants (Basel, Switzerland)·2025
Same author

Remote ischemic preconditioning prevents sarcolemmal-associated proteolysis by MMP-2 inhibition.

Molecular and cellular biochemistry·2023
Same author

Mitochondrial H<sub>2</sub>O<sub>2</sub> metabolism as central event of heart complex I syndrome in early diabetes.

Free radical biology & medicine·2023
Same author

Reprint of: Production of Superoxide Radicals and Hydrogen Peroxide by NADH- Ubiquinone Reductase and Ubiquinol-Cytochrome c Reductase from Beef-Heart Mitochondria.

Archives of biochemistry and biophysics·2022
Same author

Temporal evolution of cardiac mitochondrial dysfunction in a type 1 diabetes model. Mitochondrial complex I impairment, and H<sub>2</sub>O<sub>2</sub> and NO productions as early subcellular events.

Free radical biology & medicine·2020

Area of Science:

  • Mitochondrial Physiology
  • Biochemistry
  • Cellular Respiration

Background:

  • Mitochondria play a crucial role in cellular energy production and signaling.
  • Nitric oxide (NO) is a key signaling molecule with diverse physiological functions.
  • Mitochondrial nitric oxide synthase (mtNOS) is responsible for NO production within mitochondria.

Purpose of the Study:

  • To investigate the regulation of nitric oxide (NO) release from coupled mitochondria.
  • To determine the role of mitochondrial metabolic state and membrane potential in controlling NO production.
  • To elucidate the mechanisms underlying mtNOS activity.

Main Methods:

  • Measurement of NO release rates in isolated heart, liver, and kidney mitochondria under different metabolic states (state 3 and state 4).

Related Experiment Videos

  • Assessment of the influence of membrane potential and intramitochondrial pH on NO production.
  • Analysis of substrate (L-arginine, NADPH) concentrations and their relation to mtNOS activity.

    • Main Results:

    • NO release was significantly lower (40-45%) in state 3 compared to state 4 across different organs.
    • Mitochondrial membrane potential, not intramitochondrial pH, was identified as the primary driver of mtNOS activity.
    • NO release showed an exponential dependence on membrane potential, similar to mitochondrial H2O2 production.

    Conclusions:

    • Mitochondrial metabolic state directly influences NO release rates.
    • mtNOS activity is voltage-dependent, with membrane potential being a key regulatory factor.
    • These findings highlight the importance of mitochondrial membrane potential in controlling NO signaling pathways.